Aeterna Zentaris

                   

BUYINS.NET: CHA, GBX, KERX, SGXP, SUPG, TRMD Have Been Removed From Naked Short List Today

tmcnet.com     Jul 11, 2008   20 related          

BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold list: China Telecom Corp. Ltd. (NYSE: CHA), The Greenbrier Companies Inc. (NYSE:...                

comments

                   

BUYINS.NET: KERX, MITI, OTEX, SDTH, SVNT, INBG Have Also Been Added To Naked Short List Today

tmcnet.com     Jul 2, 2008   24 related          

BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold list: Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Micromet Inc. (NASDAQ: MITI), Open...                

comments

AEterna Zentaris Inc divests Quebec City building

m2.com     Jun 30, 2008          

AEterna Zentaris Inc (NASDAQ:AEZS) (TSX:AEZ), a biopharmaceutical company focused on endocrine therapy and oncology, declared on 27 June that the company has closed the sale of its Quebec City property for a purchase price of...                

comments

AEterna Zentaris Sells Quebec City Building for $7.1 million

tmcnet.com     Jun 27, 2008   4 related          

Attention Business/Financial Editors All amounts are in U.S. dollars QU?BEC CITY, June 27 /CNW Telbec/ - AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ;), a global biopharmaceutical company focused on endocrine therapy and...                

comments

                   

Solid Tumor Space Companies Examined in Wall Street Transcript Biotechnology Report (Wall Street...

yahoo.com     Jun 27, 2008   3 related          

67 WALL STREET, New York - The Wall Street Transcript has just published its Biotechnology issue, a report offering a timely review of the sector to serious investors and industry executives. The full issue is available by...                

comments

                   

Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients...

yahoo.com     Jun 3, 2008   2 related          

Keryx Biopharmaceuticals, Inc. today announced that phase 2 results of perifosine in patients with relapsed/refractory Waldenstroms macroglobulinemia was presented at the 44th Annual Meeting of the American Society of Clinical Oncology.                

comments

                   

Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical...

drugs.com     Jun 3, 2008   3 related          

Phase 2 Results of Perifosine in the Treatment of Patients with Relapsed/Refractory Waldenstrom's Macroglobulinemia to be presented Tomorrow, Tuesday, June 3rd at 12:00pm in Room E450a NEW YORK, June 02, 2008 /PRNewswire-FirstCall/...                

comments

Paladin Reports 2008 First Quarter Financial Results

drugpolicycentral.com     May 15, 2008          

Entered into a Canadian Co-Promotion Agreement for Tridural(TM) once-daily tramadol with Nycomed Canada Inc. Also during the quarter, Paladin and Nycomed entered into a Canadian Co-Promotion Agreement for Tridural(TM) once-daily tramadol product. (Thu May 15 04:48:51 2008...                

comments

AEterna Zentaris: First Patient Dosing for Safety Trial of Phase 3 Program with Cetrorelix in...

bionity.com     May 16, 2008   8 related          

16 May 2008 - AEterna Zentaris Inc. reported dosing has commenced in the safety study of the Company's Phase 3 program with cetrorelix in benign prostatic hyperplasia (BPH). Cetrorelix, a novel investigational luteinizing hormone-releasing hormone (LHRH) antagonist, is the Company's flagship...                

comments

Richard Bordeleau to join Advitech's Board of Directors

newswire.ca     May 8, 2008          

TSX VENTURE EXCHANGE: AVI QUEBEC CITY, May 8 /CNW Telbec/ - The management of Advitech Inc. ("Advitech" or the "Company") (TSX Venture Exchange: AVI) will propose today at the Annual General Meeting of the Company the addition of Mr. Richard Bordeleau as candidate to...                

comments

1 2 3 4 next »